More vaccines, more infections: Devastating Cleveland study passes peer review
Peer reviewed study finds vaccines make Covid infection more likely.

Mike Campbell

May 30, 2023

The devastating Cleveland study that found the more COVID vaccines individuals receive, the more likely they are to be infected with COVID — has passed peer review. 

More vaccines, more infections: Devastating Cleveland study passes peer review

Researchers included over 50,000 participants in their study, all who were employees at the Cleveland Clinic in Ohio.

“The association of increased risk of COVID-19 with higher numbers of prior vaccine doses in our study, was unexpected,” researchers stated.

In January, prior to the study passing peer review, several vaccine skeptics disseminated the alarming “pre-print” study. Twitter tagged posts about the pre-print with Community Notes to inform social media users that it hadn’t yet passed peer review.

But now that the study has been peer reviewed, it’s officially a scientific finding that vaccines not only don’t help prevent infection, but they make getting infected more likely — an astonishing hit to the so-called effective vaccines that’s known as “negative efficacy.” 

Compared to unvaccinated individuals:

  • Participants who’d received one Covid vaccine were 1.7 times more likely to test positive for Covid
  • Participants who’d received two Covid vaccines were 2.63 times more likely to test positive for Covid
  • Participants who’d received three Covid vaccines were 3.1 times more likely to test positive for Covid
  • Participants who’d received four or more Covid vaccines were 3.8 times more like to test positive for Covid

Researchers said that a simplistic explanation for the startling results would be that higher-risk individuals received more vaccines. 

“However, the majority of subjects in this study were generally young individuals and all were eligible to have received at least three doses of vaccine by the study start date, and which they had every opportunity to do,” they said. 

In other words, most individuals who had received three shots or less were eligible for more but chose to ignore the CDC’s guidance on staying “up-to-date” on COVID vaccines.

The study showed risks over three months, starting September 12, 2022. This was the first day the bivalent COVID vaccine became available to employees at the clinic. 

Researchers conclude

Researchers concluded the bivalent COVID-19 booster was only 30% effective in preventing infection.

YouTube removed a video of Dr. John Campbell presenting the data to his audience of 2.7 million followers. However, Rumble, an alternative video-sharing platform, kept the video up.

Last summer, most Canadian provinces stopped publishing information about infections according to vaccine status, right around the time the vaccinated population was beginning to show higher rates of infection per capita.

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

Pfizer has agreed to settle over 10,000 lawsuits that have been filed against it over allegedly failing to report Zantac’s possible link to cancer.

TCS Wire

May 9, 2024

Trending News

“If anything happens to me, it is Big Pharma, Big Tech, Big Gov.”

Keean Bexte

May 8, 2024

Trending News

AstraZenica throws in the towel on COVID vaccines, weeks after investing a billion (CAD) into pandemic preparedness.

Mike Campbell

May 7, 2024

Trending News

“I don’t remember talking about masks at all,” Bill Gates claimed before poking fun at people who took wearing COVID masks to the extreme.

TCS Wire

April 30, 2024

Trending News

“Investigation into these causes is ongoing.” 

TCS Wire

April 26, 2024

Trending News

The feds introduced Canada’s first ever vaccine compensation program in 2020, just before they coerced vaccines into Canadians by threatening their livelihoods, jobs, and EI. 

Mike Campbell

April 18, 2024

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.